Xeris Biopharma: Q2 Earnings Snapshot
CHICAGO (AP) _ Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $26.2 million in its second quarter.
The Chicago-based company said it had a loss of 19 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The company posted revenue of $25.3 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $25.5 million.